CHINESE JOURNAL OF DRUG EVALUATION >

2026 , Vol. 43 >Issue 2: 81 - 81-85

DOI: https://doi.org/10.2095-3593.2026.040001

Research on Evaluation and Improvement Strategies for Inspection and Testing Capabilities of Pharmaceutical Manufacturing Enterprises in Qinghai Province

Expand
  • Qinghai Provincial Drug Review and Verification Center， Qinghai Xining 810000， China

Received date: 2025-10-31

  Revised date: 2026-01-22

  Accepted date: 2026-05-19

  Online published: 2026-05-19

Fold

Abstract

Objective： To evaluate the current inspection and testing capabilities of pharmaceutical manufacturers in Qinghai Province， identify issues in personnel structure，equipment configuration， management systems， and compliance， and provide evidence for improving regional drug quality and safety， promoting high quality development of the pharmaceutical industry， and optimizing regulatory strategies. Methods： A comprehensive survey was conducted on 40 pharmaceutical manufacturers in the province using a combination of questionnaire based self-assessment and on site verification. The survey covered laboratory construction， functional zoning， types and status of testing equipment， professional background and training of testing personnel， implemented testing items， and models of commissioned testing. Results and Conclusion： The overall inspection and testing capabilities of pharmaceutical manufacturers in Qinghai Province remain at a developing stage， with deficiencies in personnel， equipment， and management. Influenced by multiple factors such as limited corporate awareness， insufficient funding， dispersed geographical distribution， and imperfect management support systems， the testing capabilities of some enterprises fail to fully meet the rising requirements for drug quality standards， thereby adversely affecting drug quality control. Enterprises should adopt a quality oriented development philosophy and continuously increase investment in the recruitment of professional talents， technical training， and advanced testing equipment. Meanwhile， drug regulatory authorities should further strengthen industrial support and guidance， and comprehensively enhance the quality and safety assurance capacity of the pharmaceutical industry chain through measures such as establishing a regional inspection and testing resources haring platform and improving the intelligent regulatory system.

Key words： ; font-size:medium; ">; font-size:medium; ">Pharmaceutical manufacturers； Drug quality； Testing capabilities； Countermeasure research

Cite this article

NIAN Yongqi, WANG Yongming, SHI Chunlan, CHENG Xiaoping, LIU Xueliang, WANG Yongjing, HAN Tianchu, HAN Dabin . Research on Evaluation and Improvement Strategies for Inspection and Testing Capabilities of Pharmaceutical Manufacturing Enterprises in Qinghai Province[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2026 , 43(2) : 81 -81-85 . DOI: 10.2095-3593.2026.040001

References

   [1] 原中华人民共和国卫生部. 《药品生产质量管理规范》（卫生部令第79号）[EB/OL]. (2011-01-17) [2025-09-30]. https：//www. samr. gov. cn/zw/zfxxgk/fdzdgknr/bgt/art/2023/art_d5e1dbaa8f284277a5f6c3e2fc840 d00. html.
     [2] 青海省药品监督管理局. 关于提升药品监管效能促进我省医药产业高质量发展的若干措施的通知(青药监〔2024〕6号) [EB/OL]. (2024-03-05）[2025-10-29]. https：//ypjgj. qinghai. gov. cn/Article/FormDetailsYJJ?Article_ID=C7C2A14C-E656-4B52-ABFE-01A2017A4E4A.
     [3] 张丽青，李烨，李景春，等. 药品生产企业质量控制实验室调查研究[J]. 中国药事，2015，29(2)：136-140.
     [4] 石春兰，刘学良，陈鹏，等. 青海省民族医疗机构检验室建设情况调研[J]. 中国药业，2024，33(18)：6-9.
     [5] 李世鹏. 关于加强药品检验检测能力的探讨[J]. 科技风，2019，(25)：219.
     [6] 杜传龙，王子千，孙西军，等. 江西省药品委托检验现状分析及监管策略探讨[J]. 药品评价，2023，20(11)：1305-1310.
     [7] 罗兰，高宏亮. 制药企业药品质量检验工作中的问题不容忽视[J]. 中国药业，2007，16(10)：13.
     [8] 庄亚蓉，陈浩，武丽梅，等. 药品检验检测机构的设备控制及应用[J]. 广州化工，2023，51(13)：145-147.
     [9] 邹玉梅. 药品生产企业质量管理体系现状分析及改进思路[J]. 中国新技术新产品，2019，(19)：107-108.
     [10] 颜若曦，曹轶，翟铁伟. 药品生产企业质量控制实验室要点与缺陷分析[J]. 中国医药工业杂志，2021，52(9)：1253-1258.
     [11] 贾志强. 新版GMP强化药品生产企业质量管理体系[J]. 福建质量管理，2016，(3)：21.
     [12] 赵艳霞，孙铜，胡德福，等. 山东省中药饮片生产企业检验能力调查与分析[J]. 中国药业，2020，29(14)：3-6.
     [13] 陈权，吴琼，薛娇. 检验检测机构仪器设备共享机制探讨[J]. 品牌与标准化，2022，(3)：101-103.
     [14] 李奇，陈婷，尹萌. 某地区药品生产企业质量控制情况调研[J]. 山东化工，2022，51(6)：121-123.
     [15] 王琦. 药品检验过程中质量控制的必要性及措施[J]. 实验室检测，2025，3(22)：194-196.
     [16] 方梦玲. 探索质量追溯形成监管闭环浙江省产品质量智慧监管平台建设显成效[J]. 中国质量监管，2021，(8)：44-45.
     [17] 张书卉，曹嘉成，王金伟，等. 信息化系统推进药品生产智慧监管的实践与思考[J]. 药品评价，2021，18(17)：1028-1031.
Options
Outlines

/

〈 〉

[an error occurred while processing this directive]